Project MILANO: Connections Between Patients With Brain Tumors and Their Pets: an Analysis of Concerns and Needs

NCT ID: NCT06899516

Last Updated: 2025-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

65 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-03-20

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Context and problem

In France, 61% of households own a pet, highlighting the significant role pets play in the daily lives. Patients diagnosed with brain tumors face specific challenges that may affect their ability to care their pets, including:

* Progressive neurological deficits (cognitive and/or motor), limiting their autonomy,
* A life-threatening prognosis.

In this context, the well-being of pets when their owner's health deteriorates becomes a critical concern. Indeed:

* Social isolation and the progressive loss of physical and cognitive abilities complicate pet care, particularly during prolonged hospitalizations or in the event of death,
* The lack of appropriate facilities and care solutions causes stress for pets, who are often unprepared for such transitions, and adds to the emotional burden on patients.

Why focus on patients with brain tumors?

* These patients have specific needs due to the rapid progression of their condition,
* A local study showed that 12% of patients with gliomas live alone, a significantly higher rate than in other cancer types. Patients who live alone are particularly exposed to issues related to their pet's future,
* Given the high morbidity and mortality associated with brain tumors, proactive planning for pet care is particularly urgent.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Brain (Nervous System) Cancers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pet-owning brain tumour patients

To assess the concerns and needs of patients with brain tumors regarding their pets, in order to plan for the pets' future when their owners are hospitalized, unable to care for them due to their condition, or in the event of their death.

The Lexington Attachment to Pets Scale (LAPS; Johnson, Garrity, & Stallones, 1992)

Intervention Type OTHER

The LAPS is a established tool for measuring the emotional bond between humans and their animal companions. Animal attachment is assessed according to three factors: the bond between owners and their dogs or cats, the closeness of the human-animal relationship, and the importance of the animal in the owner's life (Johnson et al., 1992). Higher scores indicate greater attachment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The Lexington Attachment to Pets Scale (LAPS; Johnson, Garrity, & Stallones, 1992)

The LAPS is a established tool for measuring the emotional bond between humans and their animal companions. Animal attachment is assessed according to three factors: the bond between owners and their dogs or cats, the closeness of the human-animal relationship, and the importance of the animal in the owner's life (Johnson et al., 1992). Higher scores indicate greater attachment.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with a brain tumor.
* Patients who own at least one pet.

Exclusion Criteria

* Patients who decline to participate in the study.
* Patients unable to complete the questionnaire.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Saint Etienne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carole Ramirez, Md

Role: PRINCIPAL_INVESTIGATOR

CHU de SAINT-ETIENNE

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Saint Etienne

Saint-Etienne, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Carole Ramirez, Md

Role: CONTACT

(0)477829326 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Carole Ramirez, Md

Role: primary

(0)477829326 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRBN252025/CHUSTE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

HYPONCO - Hypoxia in Brain Tumors
NCT01200134 COMPLETED PHASE2
Coping With High Grade Glioma
NCT00815152 TERMINATED NA